Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Peer Review reports

From: Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial

Original Submission
18 Feb 2009 Submitted Original manuscript
19 Feb 2009 Author responded Author comments - Anne Fiquet
Resubmission - Version 2
19 Feb 2009 Submitted Manuscript version 2
12 Mar 2009 Author responded Author comments - Anne Fiquet
Resubmission - Version 3
12 Mar 2009 Submitted Manuscript version 3
Publishing
14 Apr 2009 Editorially accepted
14 Apr 2009 Article published 10.1186/1741-7015-7-16

You can find further information about peer review here.

Back to article page